List of Contributors
Nancy Adelman, Takeshi Yoshida, Gale A. Granger(University of California, Irvine), Ralph Snyderman(Duke University), S Kontiainen, Zuhair K. Ballas(University of Iowa), Eberhard Wecker, Byron H. Waksman(Yale University), Pierluigi E. Bigazzi, Sharon M. Wahl(National Institutes of Health), Sarah Howie(Centre for Inflammation Research), Joost J. Oppenheim(Frederick National Laboratory for Cancer Research), Igal Gery(National Eye Institute), Monte S. Meltzer, Marc Feldmann(University of Oxford), Edgar Pick(Tel Aviv University), Carl F. Ware(Sanford Burnham Prebys Medical Discovery Institute), Carl Waltenbaugh, David L. Rosenstreich(Montefiore Medical Center), Lois B. Epstein, John J. Farrar, Stanley Cohen, Marilyn C. Pike(Bethesda Hospital), Charles W. Parker(Washington University in St. Louis), Harold F. Dvorak(Beth Israel Deaconess Medical Center), Anneliese Schimpl, L. Meadows, M. Elizabeth Hammond(Harvard University), Steven B. Mizel(Pennsylvania State University), William J. Koopman(University of Alabama at Birmingham), Heinz G. Remold(Brigham and Women's Hospital), Donald Metcalf(Walter and Eliza Hall Institute of Medical Research), John R. David(Harvard University), Christopher S. Henney(Seattle University), John C. Hiserodt, Philip R. Davies(Cardiff University)
Cited by 0
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
|Nature|1985|1.6k
POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS
|The Journal of Experimental Medicine|1972|910
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.
|The Journal of Experimental Medicine|1989|765